Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 3651 to 3675 of about 5880

Previous 25

Website Changes

03/30/2008

Carmustine wafers: localized delivery of chemotherapeutic agents in CNS malignancies.

03/30/2008

The harm-benefit tradeoff in "bad deal" trials.

03/27/2008

03/22/2008

Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer

03/22/2008

Dan`s Fund Created at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute to support Brain Cancer Research

03/18/2008

A fatal outcome in a patient with glioblastoma multiforme after receiving high-dose methotrexate.

03/18/2008

Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).

03/18/2008

Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas

03/18/2008

Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas.

03/18/2008

Efficacy of stereotactic radiosurgery as a salvage treatment for recurrent malignant gliomas.

03/18/2008

Cannabinoids inhibit glioma cell invasion by down-regulating matrix metalloproteinase-2 expression.

03/18/2008

Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme.

03/18/2008

Myelosuppression in patients benefiting from imatinib with hydroxyurea for recurrent malignant gliomas.

03/18/2008

Prolonged and severe myelosuppression in two patients after low-dose temozolomide treatment- case study and review of literature.

03/18/2008

Complete response after one cycle of temozolomide in an elderly patient with glioblastoma and poor performance status.

03/18/2008

Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

03/18/2008

Anti-brain cancer drug has side-effect

03/18/2008

Peregrine Pharmaceuticals Announces Positive Data From Cotara(R) Brain Cancer Trials

03/18/2008

Doctors See How Cancer Drug Can Damage Kidneys

03/18/2008

Signaling System May Halt Brain Cancer

03/18/2008

Genentech signals strong Avastin sales

03/18/2008

Dan`s Fund created at Ohio State University

03/18/2008

Updated survivor story Tom K.

03/17/2008

2nd Annual Bryan`s Run Saturday, March 29 to support Bryan`s Dream Foundation

03/10/2008

Bevacizumab (Avastin) for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.

Our privacy / cookie policy has changed.
Click HERE to read it!